Gladstone NOW: The Campaign Join Us on the Journey✕
91 - 105 of 124 Results Clear All
Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease
Institutional News Congenital Heart Disease Cardiovascular Disease Bruneau Lab
Learn how Gladstone's three founding trustees created a culture of risk taking.
History Institutional News
Gladstone trustees have a long history of making bold decisions
History Institutional News Cardiovascular Disease
The National Institutes of Health renews its funding of a promising internship program at Gladstone Institutes
Office of the President Student Outreach and Science Education Institutional News Ott Lab Diversity
Learn about Gladstone's current president in this video about our 40th anniversary.
History Institutional News
Learn about Gladstone's second president in this video celebrating our 40th anniversary.
History Institutional News
Learn more about Gladstone's founding President in this video celebrating our 40th anniversary.
History Institutional News Mahley Lab
A look at the distinct eras defined by Gladstone’s three presidents
History Institutional News Mahley Lab Srivastava Lab
His entire career, Warner Greene has had a singular mission—to find a cure for HIV.
Institutional News HIV/AIDS Center for HIV Cure Research Virology Greene Lab
Learn more about Gladstone Institutes' namesake in this video celebrating our 40th anniversary.
History Institutional News
Gladstone’s namesake left a lasting legacy after humble beginnings
History Institutional News
Shipman will build new technologies to understand the development of the brain
Institutional News News Release Profile Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing Stem Cells/iPSCs
Marius Wernig was selected for his groundbreaking research in cellular reprogramming and stem cell–based therapies for genetic disease.
Awards Institutional News Ogawa Stem Cell Prize Stem Cells/iPSCs
Robert Wicks appointed the new vice president of philanthropy
Philanthropy Institutional News
The co-inventor of CRISPR genome editing technology expands research collaborations to San Francisco’s Mission Bay research community
